HealthDay - THURSDAY, Feb. 24 (HealthDay News) -- Fewer men at a large U.S. health-care network are undergoing prostate-specific antigen (PSA) screening for prostate cancer since the release of guidelines in 2008 and the publication of two large studies a few years ago, say researchers.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.